Avant Global

Type

Venture Capital

Status

Active

Location

Las Vegas, United States

Total investments

56

Average round size

5M

Portfolio companies

46

Rounds per year

2.33

Lead investments

1

Follow on index

0.18

Exits

7

Stages of investment
SeedPrivate EquityEarly Stage Venture
Areas of investment
BiotechnologyInternetFinTechInformation TechnologyHuman ResourcesMachine LearningHealth CareSaaSEnterprise SoftwareContent

Summary

Avant Global appeared to be the VC, which was created in 1999. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Santa Barbara.

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 1 or 4 of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Vera, Butterfly.ai, Sword Diagnostics. Among the most popular fund investment industries, there are FinTech, Machine Learning.

The top activity for fund was in 2013. The increased amount of exits for fund were in 2018. The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars. Opposing the other organizations, this Avant Global works on 5 percentage points less the average amount of lead investments.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Avant Global, startups are often financed by Y Combinator, Lux Capital, Tectonic Capital. The meaningful sponsors for the fund in investment in the same round are RRE Ventures, Winklevoss capital, Sherpa Capital. In the next rounds fund is usually obtained by RRE Ventures, iNovia Capital, Y Combinator.

The current fund was established by Demetri Argyropoulos. Besides them, we counted 3 critical employees of this fund in our database.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistFintechAI/Big DataBiotech/Life SciencesConsumer/Retail Show 3 more
Stage focus
SeedSeries A
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
56
Lead investments
1
Exits
7
Rounds per year
2.33
Follow on index
0.18
Investments by industry
  • Health Care (8)
  • Internet (7)
  • SaaS (7)
  • FinTech (7)
  • Human Resources (6)
  • Show 101 more
Investments by region
  • United States (53)
  • Finland (1)
  • Canada (1)
  • Germany (1)
Peak activity year
2014
Number of Unicorns
6
Number of Decacorns
6

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
588M
Group Appearance index
0.14
Avg. company exit year
5
Avg. multiplicator
0.66
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
BlueLayer 12 Dec 2022 Software Seed Berlin, Berlin, Germany
Owl biomedical 01 Jul 2011 Biotechnology, Health Care, Medical Device Seed United States, California, Santa Barbara

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.